293 related articles for article (PubMed ID: 19549032)
1. Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy?
Okumura Y
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):994-6. PubMed ID: 19549032
[No Abstract] [Full Text] [Related]
2. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
4. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?
Dagres N; Hindricks G; Kottkamp H; Sommer P; Gaspar T; Bode K; Arya A; Husser D; Rallidis LS; Kremastinos DT; Piorkowski C
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1014-9. PubMed ID: 19490383
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.
Ling Z; Jia F; Xu Y; Su L; Liu Z; Du H; Yang X; Lan X; Xiao P; Chen W; Fan J; Luo S; Yin Y; Nazarian S
Int J Cardiol; 2014 May; 173(2):345-6. PubMed ID: 24679686
[No Abstract] [Full Text] [Related]
6. Periprocedural anticoagulation for atrial fibrillation ablation.
Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
Lip GY
Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
[No Abstract] [Full Text] [Related]
8. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
9. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Lane DA; Lip GY
Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
[No Abstract] [Full Text] [Related]
10. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.
Hakalahti A; Uusimaa P; Ylitalo K; Raatikainen MJ
Europace; 2011 May; 13(5):640-5. PubMed ID: 21398311
[TBL] [Abstract][Full Text] [Related]
11. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
[TBL] [Abstract][Full Text] [Related]
12. Reducing the risk for stroke in patients who have atrial fibrillation.
Garcia DA; Hylek E
Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
[TBL] [Abstract][Full Text] [Related]
13. Safety of single transseptal puncture for ablation of atrial fibrillation: retrospective study from a large cohort of patients.
Hammerstingl C; Lickfett L
J Cardiovasc Electrophysiol; 2008 May; 19(5):E36; author reply E37. PubMed ID: 18363696
[No Abstract] [Full Text] [Related]
14. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Tay KH; Lip GY; Lane DA
Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
[No Abstract] [Full Text] [Related]
16. Anticoagulation for patients with atrial fibrillation in ambulatory care settings.
Niska R; Han B
J Am Board Fam Med; 2009; 22(3):299-306. PubMed ID: 19429736
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
Hylek EM
Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
[No Abstract] [Full Text] [Related]
18. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.
Page SP; Herring N; Hunter RJ; Withycombe E; Lovell M; Wali G; Betts TR; Bashir Y; Dhinoja M; Earley MJ; Sporton SC; Rajappan K; Schilling RJ
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):585-90. PubMed ID: 24641450
[TBL] [Abstract][Full Text] [Related]
19. Less benefit from warfarin in diabetics after myocardial infarction?
Smith PJ; Hurlen M; Abdelnoor M; Arnesen H
Cardiology; 2008; 111(3):161-6. PubMed ID: 18434719
[TBL] [Abstract][Full Text] [Related]
20. Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary?
Ha AC; Hindricks G; Birnie DH; Verma A
Curr Opin Cardiol; 2015 Jan; 30(1):1-7. PubMed ID: 25389647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
